Weiman He

670 total citations
11 papers, 531 citations indexed

About

Weiman He is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Weiman He has authored 11 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Weiman He's work include Cancer-related molecular mechanisms research (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and RNA modifications and cancer (2 papers). Weiman He is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and RNA modifications and cancer (2 papers). Weiman He collaborates with scholars based in China, United States and Hong Kong. Weiman He's co-authors include Jerrold M. Olefsky, Yaacov Barak, Philip D.G. Miles, Ronald M. Evans, Haipeng Xiao, Yanbing Li, Yingying Gong, Li Xiong, Rengyun Liu and Lei Su and has published in prestigious journals such as Journal of Clinical Investigation, Oncogene and Endocrinology.

In The Last Decade

Weiman He

11 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiman He China 8 421 203 120 110 56 11 531
Adhiraj Lanba United States 3 395 0.9× 106 0.5× 70 0.6× 105 1.0× 44 0.8× 3 528
Wen‐Yu Hsiao United States 7 258 0.6× 210 1.0× 73 0.6× 132 1.2× 29 0.5× 12 481
Catherine Esnous France 9 250 0.6× 191 0.9× 90 0.8× 92 0.8× 44 0.8× 10 438
Kristina Li United States 8 268 0.6× 133 0.7× 51 0.4× 156 1.4× 26 0.5× 11 501
Radha Uppala United States 10 341 0.8× 156 0.8× 130 1.1× 137 1.2× 22 0.4× 11 576
Michael G. Borland United States 14 417 1.0× 75 0.4× 175 1.5× 46 0.4× 34 0.6× 16 508
M. Furkan Burak United States 7 196 0.5× 115 0.6× 37 0.3× 119 1.1× 51 0.9× 11 338
Núria Matías Spain 8 233 0.6× 128 0.6× 63 0.5× 285 2.6× 88 1.6× 12 562
Elena Lopez-Guadamillas Spain 5 228 0.5× 204 1.0× 45 0.4× 83 0.8× 16 0.3× 5 419
Nuoqi Chen China 4 183 0.4× 59 0.3× 176 1.5× 76 0.7× 52 0.9× 5 348

Countries citing papers authored by Weiman He

Since Specialization
Citations

This map shows the geographic impact of Weiman He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiman He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiman He more than expected).

Fields of papers citing papers by Weiman He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiman He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiman He. The network helps show where Weiman He may publish in the future.

Co-authorship network of co-authors of Weiman He

This figure shows the co-authorship network connecting the top 25 collaborators of Weiman He. A scholar is included among the top collaborators of Weiman He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiman He. Weiman He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
He, Weiman, Zhen Cheng, Zijun Huo, et al.. (2023). STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice. Endocrinology. 164(3). 3 indexed citations
2.
He, Weiman, Xuejie Wang, Bo Lin, et al.. (2023). STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma. Frontiers in Endocrinology. 14. 1076640–1076640. 7 indexed citations
3.
Hu, Huijuan, Shubin Hong, Weiman He, et al.. (2023). CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis. Cellular Oncology. 46(6). 1777–1789. 8 indexed citations
4.
Chen, Mengke, Ye Sang, Wenting Jiang, et al.. (2023). Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer. BMC Cancer. 23(1). 363–363. 1 indexed citations
5.
Chen, Shuhong & Weiman He. (2023). Metabolome-Wide Mendelian Randomization Assessing the Causal Relationship Between Blood Metabolites and Bone Mineral Density. Calcified Tissue International. 112(5). 543–562. 8 indexed citations
6.
Hong, Shubin, Yubin Xie, Zhen Cheng, et al.. (2022). Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. Oncogene. 41(47). 5121–5132. 24 indexed citations
7.
Gong, Yingying, Xuejie Wang, Weiman He, et al.. (2021). METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Molecular Therapy. 30(2). 932–946. 81 indexed citations
8.
Xiong, Li, Li Chen, Liting Wu, et al.. (2021). Lipotoxicity-induced circGlis3 impairs beta cell function and is transmitted by exosomes to promote islet endothelial cell dysfunction. Diabetologia. 65(1). 188–205. 25 indexed citations
9.
Cheng, Zhen, Shuang Yu, Weiman He, et al.. (2021). Selenite Induces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Dependent Inhibition of the AKT/mTOR Pathway in Thyroid Cancer. Frontiers in Oncology. 11. 668424–668424. 14 indexed citations
10.
Xiong, Li, Yingying Gong, Liting Wu, et al.. (2020). LncRNA-Malat1 is Involved in Lipotoxicity-Induced ß-cell Dysfunction and the Therapeutic Effect of Exendin-4 via Ptbp1. Endocrinology. 161(7). 19 indexed citations
11.
Miles, Philip D.G., Yaacov Barak, Weiman He, Ronald M. Evans, & Jerrold M. Olefsky. (2000). Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. Journal of Clinical Investigation. 105(3). 287–292. 341 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026